VV
Voorhees Seth Van
Chief Financial Officer

Voorhees Seth Van insider trades: NRX Pharmaceuticals (NRXP) stock purchases

Chief Financial Officer, NRX Pharmaceuticals Last trade Dec 16, 2022 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2006
4
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Voorhees reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 16, 2022NRXP↑ Buy$33K
Nov 25, 2022NRXP↑ Buy$18K
Jun 15, 2021PDSB↑ Buy$150K
Sep 12, 2017REFR↑ Buy$5K
Jun 19, 2014REFR↑ Buy$11K
Feb 10, 2011REFR↑ Buy$104K
Feb 10, 2011REFR↑ Buy$104K
Mar 1, 2006APFC↑ Buy$34K
Feb 17, 2006APFC↑ Buy$84K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Voorhees Seth Van's insider trades

Voorhees Seth Van is Chief Financial Officer at NRX Pharmaceuticals (NRXP). Since Feb 17, 2006, Voorhees has reported 9 open-market purchases worth $542K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NRXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.